98 related articles for article (PubMed ID: 11336609)
1. The psychopharmacology of autism spectrum disorder and Rett syndrome.
Persico AM; Ricciardello A; Cucinotta F
Handb Clin Neurol; 2019; 165():391-414. PubMed ID: 31727226
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).
Iffland M; Livingstone N; Jorgensen M; Hazell P; Gillies D
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD011769. PubMed ID: 37811711
[TBL] [Abstract][Full Text] [Related]
3. Chemical Modulators for Targeting Autism Spectrum Disorders: From Bench to Clinic.
Lim S; Lee S
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014340
[TBL] [Abstract][Full Text] [Related]
4. The effect of omega-3 fatty acids supplementation on social and behavioral disorders of children with autism: a randomized clinical trial.
Doaei S; Bourbour F; Teymoori Z; Jafari F; Kalantari N; Abbas Torki S; Ashoori N; Nemat Gorgani S; Gholamalizadeh M
Pediatr Endocrinol Diabetes Metab; 2021; 27(1):12-18. PubMed ID: 33599431
[TBL] [Abstract][Full Text] [Related]
5. A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report.
Ponton JA; Smyth K; Soumbasis E; Llanos SA; Lewis M; Meerholz WA; Tanguay RL
J Med Case Rep; 2020 Sep; 14(1):162. PubMed ID: 32958062
[TBL] [Abstract][Full Text] [Related]
6. Assessment of knowledge about childhood autism spectrum disorder among healthcare workers in Makkah- Saudi Arabia.
Hayat AA; Meny AH; Salahuddin N; M Alnemary F; Ahuja KR; Azeem MW
Pak J Med Sci; 2019; 35(4):951-957. PubMed ID: 31372123
[TBL] [Abstract][Full Text] [Related]
7. Safety and Tolerability of Antipsychotic Medication in Individuals with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.
Alfageh BH; Wang Z; Mongkhon P; Besag FMC; Alhawassi TM; Brauer R; Wong ICK
Paediatr Drugs; 2019 Jun; 21(3):153-167. PubMed ID: 31134563
[TBL] [Abstract][Full Text] [Related]
8. A Short Review on the Current Understanding of Autism Spectrum Disorders.
Park HR; Lee JM; Moon HE; Lee DS; Kim BN; Kim J; Kim DG; Paek SH
Exp Neurobiol; 2016 Feb; 25(1):1-13. PubMed ID: 26924928
[TBL] [Abstract][Full Text] [Related]
9. Adverse effects of risperidone in children with autism spectrum disorders in a naturalistic clinical setting at siriraj hospital, Thailand.
Boon-Yasidhi V; Jearnarongrit P; Tulayapichitchock P; Tarugsa J
Psychiatry J; 2014; 2014():136158. PubMed ID: 24790986
[TBL] [Abstract][Full Text] [Related]
10. Acupuncture for autism spectrum disorders (ASD).
Cheuk DK; Wong V; Chen WX
Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD007849. PubMed ID: 21901712
[TBL] [Abstract][Full Text] [Related]
11. An Open-label Trial of Risperidone and Fluoxetine in Children with Autistic Disorder.
Desousa A
Indian J Psychol Med; 2010 Jan; 32(1):17-21. PubMed ID: 21799554
[TBL] [Abstract][Full Text] [Related]
12. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children.
Schuchardt JP; Huss M; Stauss-Grabo M; Hahn A
Eur J Pediatr; 2010 Feb; 169(2):149-64. PubMed ID: 19672626
[TBL] [Abstract][Full Text] [Related]
13. Risperidone for autism spectrum disorder.
Jesner OS; Aref-Adib M; Coren E
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD005040. PubMed ID: 17253538
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapeutic management of autism.
Posey DJ; McDougle CJ
Expert Opin Pharmacother; 2001 Apr; 2(4):587-600. PubMed ID: 11336609
[TBL] [Abstract][Full Text] [Related]
15. The status of pharmacotherapy for autism spectrum disorders.
Myers SM
Expert Opin Pharmacother; 2007 Aug; 8(11):1579-603. PubMed ID: 17685878
[TBL] [Abstract][Full Text] [Related]
16. Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders.
Malone RP; Gratz SS; Delaney MA; Hyman SB
CNS Drugs; 2005; 19(11):923-34. PubMed ID: 16268664
[TBL] [Abstract][Full Text] [Related]
17. Treatment of aggression in children and adolescents with autism and conduct disorder.
McDougle CJ; Stigler KA; Posey DJ
J Clin Psychiatry; 2003; 64 Suppl 4():16-25. PubMed ID: 12672261
[TBL] [Abstract][Full Text] [Related]
18. The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.
Posey DJ; McDougle CJ
Harv Rev Psychiatry; 2000; 8(2):45-63. PubMed ID: 10902094
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate an effective treatment for ADHD?
McDougle CJ
J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
